TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
High Tide ( (TSE:HITI) ) has issued an update.
High Tide Inc. announced that its executives will present at several upcoming investor conferences, highlighting the company’s growth and strategic milestones. The acquisition of a majority stake in Remexian has strengthened High Tide’s position in Germany’s medical cannabis market, while its expansion in Canada continues with plans to surpass 300 Canna Cabana stores. These developments, along with the success of its loyalty-driven discount club model, underscore High Tide’s competitive edge and long-term potential in the global cannabis sector.
The most recent analyst rating on (TSE:HITI) stock is a Buy with a C$8.00 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
Spark’s Take on TSE:HITI Stock
According to Spark, TipRanks’ AI Analyst, TSE:HITI is a Neutral.
High Tide’s overall stock score is driven by strong financial performance and positive earnings call sentiment, highlighting growth in retail expansion and market share. However, the technical indicators suggest the stock may be overbought, and the negative P/E ratio reflects ongoing profitability challenges.
To see Spark’s full report on TSE:HITI stock, click here.
More about High Tide
High Tide Inc. is a leading retail-forward cannabis enterprise with a focus on delivering value across all components of the cannabis industry. Its subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally, with a significant presence in Canada. The company also operates in the medical cannabis distribution sector through Remexian Pharma GmbH, a key player in Germany’s medical cannabis market.
Average Trading Volume: 71,087
Technical Sentiment Signal: Buy
Current Market Cap: C$410.1M
For an in-depth examination of HITI stock, go to TipRanks’ Overview page.